Sahajanand Medical Technologies (SMT), a cardiovascular device company, has announced the appointment of two new members to its Board of Directors: Harvinder Singh as Independent Director and Priyanka Cohen as Director.
Harvinder Pal Singh currently serves as Executive Vice President and President, International, at Integra Life Sciences Corporation. He brings several years of leadership experience from roles at Integra and Abbott Laboratories. At Abbott, he held various global leadership positions across commercial functions. SMT stated that his understanding of international Medtech markets and commercial innovation is expected to support the company’s global growth strategy.
Priyanka Dhirajlal Cohen, a trial attorney by profession and one of the company’s promoters, joins the board with experience in law, governance and public service. She has previously worked at the U.S. Department of Justice and the District of Columbia Court of Appeals. SMT noted that her legal background and alignment with the company’s long-term objectives would contribute to the Board’s governance and decision-making processes.
Commenting on the appointments, Jose Calle Gordo, Chairman of SMT, said, “We are thrilled to welcome Harvinder Singh and Priyanka Cohen to the SMT Board. We believe Singh’s global Medtech expertise and proven record in building high-performance businesses aligns with SMT’s next phase of international expansion and Cohen brings a unique blend of legal expertise, and policy insight that will be instrumental in steering SMT’s governance and long-term strategy.”
The post Sahajanand Medical Technologies appoints Harvinder Singh and Priyanka Cohen to Board of Directors appeared first on Express Healthcare.
